← Scroll for more →
Financial Statements — CLS
Balance Sheet
(in billions USD)| Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q4 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.96 | 0.54 | 0.38 | 0.60 | 0.31 | 0.31 | 0.30 | 0.42 | 0.37 | 0.37 | 0.39 |
| Inventory | 4.51 | 3.40 | 2.67 | 2.19 | 2.05 | 1.92 | 1.79 | 1.76 | 2.11 | 2.35 | 1.70 |
| Total Current Assets | 12.54 | 7.57 | 6.40 | 5.67 | 5.14 | 4.77 | 4.38 | 4.51 | 4.51 | 4.33 | 3.44 |
| Property, Plant & Equipment | 1.40 | 1.03 | 0.71 | 0.59 | 0.55 | 0.55 | 0.54 | 0.54 | -- | -- | -- |
| Goodwill | 0.33 | 0.33 | 0.33 | 0.33 | 0.34 | 0.34 | 0.34 | 0.34 | -- | -- | -- |
| Intangible Assets | 0.23 | 0.24 | 0.26 | 0.27 | 0.28 | 0.29 | 0.30 | 0.31 | -- | -- | -- |
| Total Non-current Assets* | 2.59 | 2.21 | 1.86 | 1.54 | 1.46 | 1.47 | 1.46 | 1.48 | -- | -- | -- |
| Total Assets | 15.14 | 9.79 | 8.26 | 7.21 | 6.61 | 6.24 | 5.83 | 5.99 | -- | -- | -- |
| Accounts Payable | 5.04 | 3.82 | 3.09 | 1.87 | 1.68 | 1.60 | 1.38 | 1.29 | -- | -- | -- |
| Total Current Liabilities | 7.77 | 6.18 | 5.08 | 3.94 | 3.50 | 3.32 | 3.05 | 3.02 | 3.22 | 3.06 | 2.25 |
| Long-term Debt | 0.79 | 0.78 | 0.75 | 0.75 | 0.76 | 0.85 | 0.92 | 0.77 | -- | -- | -- |
| Total Non-current Liabilities* | 1.15 | 1.13 | 1.08 | 1.06 | 1.08 | 1.16 | 1.22 | 1.07 | -- | -- | -- |
| Total Liabilities | 8.92 | 7.31 | 6.16 | 5.00 | 4.58 | 4.48 | 4.28 | 4.09 | -- | -- | -- |
| Retained Earnings | -- | -- | -- | 0.41 | -- | -- | -- | (0.42) | (0.84) | (1.08) | (1.26) |
| Total Stockholder Equity | 6.21 | 2.48 | 2.10 | 2.22 | 2.03 | 1.76 | 1.56 | 1.90 | 1.77 | 1.68 | 1.46 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in billions USD) (except per-share rows)| Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5.83 | 4.70 | 4.05 | 3.65 | 3.19 | 2.89 | 2.65 | 2.55 |
| Cost of Revenue | 5.19 | 4.12 | 3.61 | 3.22 | 2.78 | 2.52 | 2.37 | 2.25 |
| Gross Profit | 0.64 | 0.58 | 0.44 | 0.43 | 0.42 | 0.37 | 0.27 | 0.30 |
| Research & Development | 0.05 | 0.05 | 0.04 | 0.03 | 0.04 | 0.03 | 0.02 | 0.02 |
| Selling, General & Admin | 0.12 | 0.06 | 0.12 | 0.07 | 0.04 | 0.04 | 0.11 | 0.06 |
| Total Operating Expenses* | 0.18 | 0.12 | 0.17 | 0.12 | 0.09 | 0.10 | 0.15 | 0.09 |
| Operating Income | 0.46 | 0.46 | 0.27 | 0.31 | 0.33 | 0.27 | 0.13 | 0.20 |
| Pretax Income | 0.46 | 0.44 | 0.26 | 0.30 | 0.31 | 0.26 | 0.11 | 0.19 |
| Tax Provision | 0.06 | 0.07 | 0.04 | 0.03 | 0.04 | 0.05 | 0.03 | 0.04 |
| Net Income | 0.40 | 0.37 | 0.21 | 0.27 | 0.27 | 0.21 | 0.09 | 0.15 |
| Basic EPS | 3.30 | 3.21 | 1.85 | 2.32 | 2.33 | 1.83 | 0.74 | 1.29 |
| Diluted EPS | 3.26 | 3.17 | 1.83 | 2.29 | 2.31 | 1.82 | 0.74 | 1.29 |
← Scroll for more columns →
* Derived from reported values
Cash Flow Statement
(in billions USD)| Metric | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 0.39 | 0.41 | 0.36 | 0.25 | 0.13 | 0.15 | 0.13 | 0.14 |
| Capital Expenditures | 0.27 | 0.26 | 0.23 | 0.09 | 0.04 | 0.03 | 0.04 | 0.05 |
| Free Cash Flow* | 0.12 | 0.15 | 0.13 | 0.16 | 0.09 | 0.12 | 0.09 | 0.10 |
| Investing Cash Flow | (0.26) | (0.27) | (0.22) | (0.09) | (0.04) | (0.04) | (0.04) | (0.05) |
| Financing Cash Flow | 3.30 | 0.01 | (0.36) | 0.13 | (0.10) | (0.11) | (0.21) | (0.07) |
← Scroll for more columns →
* Derived from reported values